OneMedNet Corp. Files S-1/A Amendment

TL;DR

<b>OneMedNet Corp. has filed an S-1/A amendment, providing updated information for its registration statement.</b>

AI Summary

OneMedNet Corp (ONMDW) filed a Amended IPO Registration (S-1/A) with the SEC on April 17, 2024. OneMedNet Corp. (formerly Data Knights Acquisition Corp.) filed an S-1/A amendment on April 17, 2024. The company is incorporated in Delaware with its fiscal year ending December 31. Its business address is located at Trident Court, 1 Oakcroft Road, Chessington, Surrey, KT9 1BD. The filing relates to the Securities Act of 1933. The SIC code for OneMedNet Corp. is 8731, Services-Commercial Physical & Biological Research.

Why It Matters

For investors and stakeholders tracking OneMedNet Corp, this filing contains several important signals. This amendment updates the company's registration statement, which is crucial for potential investors to assess the company's financial health and future prospects. As a filing under the 1933 Act, this S-1/A is a key document for understanding the regulatory compliance and offering details related to OneMedNet Corp.'s securities.

Risk Assessment

Risk Level: low — OneMedNet Corp shows low risk based on this filing. The filing is an amendment to a registration statement, indicating ongoing regulatory processes rather than immediate financial performance changes.

Analyst Insight

Monitor future filings for updated financial data and business developments following this S-1/A amendment.

Key Numbers

• 2024-04-17 — Filing Date (S-1/A filing date)
• 8731 — SIC Code (Services-Commercial Physical & Biological Research)
• 1231 — Fiscal Year End (Company's fiscal year end)
• 0001849380 — Central Index Key (Company's Central Index Key)

Key Players & Entities

• OneMedNet Corp. (company) — Filer name
• Data Knights Acquisition Corp. (company) — Former company name
• 2024-04-17 (date) — Filing date
• 1933 Act (regulator) — SEC Act
• 8731 (other) — Standard Industrial Classification
• DE (other) — State of Incorporation
• 1231 (other) — Fiscal Year End
• 0001849380 (company) — Central Index Key

FAQ

Industry Context

OneMedNet Corp. operates within the commercial physical and biological research services sector.

Regulatory Implications

The filing is made under the Securities Act of 1933, which governs the registration of securities.

What Investors Should Do

1. Review the full S-1/A filing for detailed disclosures.
2. Track future SEC filings from OneMedNet Corp. for further updates.
3. Research the company's business model and market position.

Key Dates

• 2024-04-17: S-1/A Filing — Amendment to registration statement filed by OneMedNet Corp.

Year-Over-Year Comparison

This is an S-1/A filing, indicating an amendment to a previously submitted registration statement.

Key Financial Figures

• $0.0001 — 5,275 shares of common stock, par value $0.0001 per share (the "Common Stock"), of OneM
• $1,595,744.70 — f Common Stock upon conversion of up to $1,595,744.70 of OneMedNet Senior Secured Convertible
• $2.00 — ined below) subject to a floor price of $2.00 per share pursuant to the terms of the
• $4,547,500 — rsion (the "Conversion Shares) of up to $4,547,500 of funding to the Company pursuant to t
• $10.88 — Satisfaction and Discharge Agreement at $10.88 per share dated as of June 28, 2023, by
• $1 — utstanding loans converted to equity at $1 per share to Data Knights to fund its e
• $0.7535 — ii) 1,327,070 shares of Common Stock at $0.7535 (95% of VWAP 10-day average $0.7932) fo
• $0.7932 — at $0.7535 (95% of VWAP 10-day average $0.7932) for $1,000,000 investment by Dr. Thoma
• $1,000,000 — 95% of VWAP 10-day average $0.7932) for $1,000,000 investment by Dr. Thomas Kosasa, and (i
• $25,000 — of DKAC for aggregate consideration of $25,000, or approximately $0.009 per share, and
• $0.009 — sideration of $25,000, or approximately $0.009 per share, and 585,275 shares of Common
• $10.00 — with DKAC's initial public offering at $10.00 per unit, and which are subject to six
• $0.68 — and warrants as reported on Nasdaq was $0.68 per share and $0.180 per warrant. We
• $0.180 — orted on Nasdaq was $0.68 per share and $0.180 per warrant. We are an "emerging grow
• $1.235 billion — total annual gross revenue of at least $1.235 billion; the date on which we are deemed to b

Filing Documents

• forms-1a.htm (S-1/A) — 1930KB
• ex3-1.htm (EX-3.1) — 73KB
• ex3-2.htm (EX-3.2) — 154KB
• ex10-2.htm (EX-10.2) — 129KB
• ex10-3.htm (EX-10.3) — 167KB
• ex10-8.htm (EX-10.8) — 65KB
• ex10-9.htm (EX-10.9) — 54KB
• ex10-10.htm (EX-10.10) — 64KB
• ex10-11.htm (EX-10.11) — 313KB
• ex14-1.htm (EX-14.1) — 109KB
• ex23-1.htm (EX-23.1) — 4KB
• ex107.htm (EX-FILING FEES) — 51KB
• forms-1_001.jpg (GRAPHIC) — 4KB
• forms-1_002.jpg (GRAPHIC) — 5KB
• forms-1_003.jpg (GRAPHIC) — 17KB
• forms-1_004.jpg (GRAPHIC) — 29KB
• forms-1_005.jpg (GRAPHIC) — 22KB
• forms-1_006.jpg (GRAPHIC) — 25KB
• forms-1_007.jpg (GRAPHIC) — 20KB
• forms-1_008.jpg (GRAPHIC) — 14KB
• forms-1_009.jpg (GRAPHIC) — 33KB
• forms-1_010.jpg (GRAPHIC) — 29KB
• forms-1_011.jpg (GRAPHIC) — 10KB
• ex3-2_001.jpg (GRAPHIC) — 3KB
• ex10-11_001.jpg (GRAPHIC) — 5KB
• ex14-1_001.jpg (GRAPHIC) — 3KB
• ex23-1_001.jpg (GRAPHIC) — 2KB
• 0001493152-24-014918.txt (&nbsp;) — 8162KB
• onmd-20231231.xsd (EX-101.SCH) — 39KB
• onmd-20231231_cal.xml (EX-101.CAL) — 58KB
• onmd-20231231_def.xml (EX-101.DEF) — 221KB
• onmd-20231231_lab.xml (EX-101.LAB) — 327KB
• onmd-20231231_pre.xml (EX-101.PRE) — 274KB
• forms-1a_htm.xml (XML) — 758KB

DESCRIPTION OF SECURITIES WE ARE OFFERING

DESCRIPTION OF SECURITIES WE ARE OFFERING 47 SHARES ELIGIBLE FOR FUTURE SALE 49 LEGAL MATTERS 62 EXPERTS 62

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 62

LEGAL PROCEEDINGS

LEGAL PROCEEDINGS 69 WHERE YOU CAN FIND MORE INFORMATION 70 INCORPORATION OF DOCUMENTS BY REFERENCE 70 You should rely only on the information contained in this prospectus or any supplement. Neither we nor the Selling Securityholders have authorized anyone else to provide you with different information. The securities offered by this prospectus are being offered only in jurisdictions where the offer is permitted. You should not assume that the information in this prospectus or any supplement is accurate as of any date other than the date on the front of each document. Our business, financial condition, results of operations and prospects may have changed since that date. Except as otherwise set forth in this prospectus, neither we nor the Selling Securityholders have taken any action to permit a public offering of these securities outside the United States or to permit the possession or distribution of this prospectus outside the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about and observe any restrictions relating to the offering of these securities and the distribution of this prospectus outside the United States. i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we filed with the SEC using a "shelf" registration process. By using a shelf registration statement, the Selling Securityholders may sell up to 19,683,367 shares of Common Stock and up to 681,019 Warrants from time to time in one or more offerings as described in this prospectus. We will not receive any proceeds from the sale of Common Stock or Warrants by the Selling Securityholders. This prospectus also relates to the issuance by up to 12,085,275 Common Stock upon the exercise of Warrants. We will receive the proceeds from any exercise of the Warrants for cash. We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus

View Full Filing

View this S-1/A filing on SEC EDGAR